Get started
Author

James Woo

Observed names: J Woo, Woo, James
ORCID: 0000-0001-6616-2852
Observed ORCID: 0000-0001-6616-2852
OpenAlex ID: A5048323082
Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study
2022 · Brendan O'Kelly, Louise Vidal, et al. · Brain Behavior & Immunity - Health · 94
PDF
Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons
2013 · Margalida Rotger, Tracy R. Glass, et al. · Clinical Infectious Diseases · 77
PDF
Candida albicans Stimulates IL-23 Release by Human Dendritic Cells and Downstream IL-17 Secretion by Vδ1 T Cells
2015 · Christina O Maher, Katie Dunne, et al. · The Journal of Immunology · 51
Assessing the impact of COVID-19 at 1-year using the SF-12 questionnaire: Data from the Anticipate longitudinal cohort study
2022 · Brendan O'Kelly, Louise Vidal, et al. · International Journal of Infectious Diseases · 36
Mental health and alcohol use among patients attending a post-COVID-19 follow-up clinic: a cohort study
2022 · John Broughan, Geoff McCombe, et al. · HRB Open Research · 5
Predictors and Outcomes for COVID-19 Re-Admissions in the Anticipate Cohort.
2022 · B O'Kelly, L Vidal, et al. · PubMed
Mental health and alcohol use among patients attending a post-COVID-19 follow-up clinic: A cohort study.
2022 · Broughan, John, McCombe, Geoff, et al. · Zenodo (CERN European Organization for Nuclear Research)
Works count: 8
Citation count: 263
H-index: 5
I10-index: 4
Year
Topic
Type